Skip to content

Ceva CEVA Royalty — Revenue

Other product segments

License
$17.82M+18.5%

Similar metrics at other companies

PTC Therapeutics logo
PTCTRoyalty — Revenue
$46.84M+28.5%
Mannkind logo
MNKDRoyalty — Revenue
$32.75M+9.1%
EyePoint, Inc.
 logo
EYPTRoyalty — Revenue
$141K-98.9%
Dianthus Therapeutics logo
DNTHRoyalty — Revenue
$0
Ultragenyx Pharmaceutical logo
RARERoyalty — Revenue
$47M-2.1%
Nuvation Bio logo
NUVBRoyalty Revenue — Revenue
$1.4M+600%

Other financials

Income statement

See full
Revenue$27.0M+11.5%
Gross profit$23.3M+12.2%
Operating income-$5.1M-16.0%
Net income-$4.5M-34.0%
EPS (diluted)-$0.21-200%

Balance sheet

See full
Cash & equivalents$21.4M+13.6%
Total debt$16.9M+249%
Total equity$338.2M+25.7%
Total assets$388.2M+25.2%

Cash flow

See full
Operating cash flow-$4.9M+34.0%
CapEx$2.3M+644%
Free cash flow-$7.2M+6.7%

Valuation

See full
Market cap$1.25B+154%
Enterprise value$1.25B+161%
P/S11.2×+6.6×

Profitability

See full
Gross margin89.9%
Operating margin-0.3%
Net margin-10.5%+26.2pp
FCF margin1%

Returns & leverage

See full
Return on equity-3.9%+4.7pp
Debt / equity0.0×
Current ratio10.3×+2.8×

Where this comes from

Reported directly by Ceva in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Ceva’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ceva's royalty — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ceva's royalty — revenue?
Ceva (CEVA) reported royalty — revenue of $9.2M in Q1 2026.
What does royalty — revenue mean?
This metric represents the net revenue recognized from royalty-based licensing agreements after excluding any assessed taxes. It reflects the core economic value generated by the company's intellectual property as end-user products containing the licensed technology are shipped. This figure is a primary indicator of the underlying market adoption and commercial success of the company's licensed signal-processing technology.